The Business Times
business-time-50

Biopharma firm AbbVie opens S$400m biologics plant in Tuas

The 120,000-sq metre facility, its first manufacturing plant in Asia, will create 250 jobs

Published Wed, Oct 4, 2017 · 09:50 PM

    Singapore

    GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.

    On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial products derived from biotechnology. (Vaccines are one example.)

    S Iswaran

    TRENDING NOW

    From shy teenager to outspoken philanthropist, Chloe Tong has come a long way.

    Grab CEO’s wife Chloe Tong on life with Anthony Tan and finding her purpose

    Stocks to watch: DBS, DFI Retail, Frasers Property, Clint, ESR-Reit, Centurion, Coliwoo

    The Starbucks-licensed business that DFI will take over reported revenue of US$750 million in 2025, with an underlying operating margin of 7%.

    DFI Retail to bag US$340 million, Starbucks business in Asia in deal with Maxim’s Caterers

    Tuas Port began operations in September 2022 and will continue to grow in phases towards its completion in the 2040s.

    Green fuels, autonomous ships: How Singapore is future-proofing its shipping industry

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More